Home / Pharmaceutical company intelligence
Wilson's Pharmaceuticals logo
Pharmaceutical company intelligence

Wilson's Pharmaceuticals

Pharmaceutical manufacturer · Islamabad · Pakistan

Islamabad-based pharmaceutical manufacturer operating since 1984 with products across major therapeutic segments and a national healthcare focus.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check23 Sep 2026Latest source-check date across this published portfolio
Latest effective price date30 Jun 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Company type
Pharmaceutical manufacturer
Address
387-388, I-9 Industrial Area, Islamabad, Pakistan
Phone
+92 51 4433630; +92 51 4443185
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
88%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000239 Wilson's Pharmaceuticals. · Islamabad
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000239 223 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Logo Url source ↗ Contact Page Url source ↗ Logo Source Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx176public portfolio records represented
REG120unique registrations represented
IDX172indexed MedInfoBase presentations
SRC4additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR160current validated price records
G57generic molecules in indexed catalogue
DF11dosage-form groups
TA12therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage91%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage94%
priced packs safely normalized per unit
Comparable-market coverage80%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixWilson's PharmaceuticalsShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/wilsons-pharmaceuticalsGenerated 23 Sep 2026Anti-infectives57 · 33%Cardiovascular39 · 23%Endocrine & metabolic25 · 15%Respiratory & allergy13 · 8%Pain & musculoskeletal11 · 6%Gastrointestinal & hepatology8 · 5%CNS & mental health6 · 3%Other therapeutic areas13 · 8%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioWilson's PharmaceuticalsDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/wilsons-pharmaceuticalsGenerated 23 Sep 2026172presentationsTablet106 · 62%Capsule20 · 12%Suspension16 · 9%Solution9 · 5%Syrup7 · 4%Inhalation6 · 3%Other forms8 · 5%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionWilson's PharmaceuticalsCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/wilsons-pharmaceuticalsGenerated 23 Sep 2026138comparable productsBelow peer median38 · 28%Near peer median58 · 42%Above peer median42 · 30%Company median price position-1.4%Lowest-price equivalents16Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsWilson's PharmaceuticalsCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/wilsons-pharmaceuticalsGenerated 23 Sep 2026Werrick Pharmaceuticals43 shared75% overlapMacter International Limited31 shared54% overlapAtco Laboratories Limited30 shared53% overlapNabiqasim Industries (Pvt) Ltd.,29 shared51% overlapThe Searle Company Limited29 shared51% overlapZafa Pharmaceutical Laboratories (P…27 shared47% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives57 products · 33%
Cardiovascular39 products · 23%
Endocrine & metabolic25 products · 15%
Respiratory & allergy13 products · 8%
Pain & musculoskeletal11 products · 6%
Gastrointestinal & hepatology8 products · 5%
CNS & mental health6 products · 3%
Vitamins, minerals & nutrition5 products · 3%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Antidiabetic medicines25 products · 15%
Fluoroquinolone antibacterials18 products · 10%
Calcium-channel blockers17 products · 10%
Analgesics / NSAIDs11 products · 6%
Penicillin antibacterials10 products · 6%
Antivirals9 products · 5%
Beta blockers7 products · 4%
Antiseptics & disinfectants6 products · 3%
Formulation footprint

Dosage forms

Tablet106 products
Capsule20 products
Suspension16 products
Solution9 products
Syrup7 products
Inhalation6 products
Cream2 products
Infusion2 products
Sachet2 products
Drops1 products
Injection1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 MYTILCiprofloxacin 12presentations 125 mg, 125 mg/5 mL, 250 mg, 250 mg/5 mL · Suspension, Capsule, Tablet #2 VoretaEmpagliflozin 10presentations 10 mg, 25 mg · Tablet #3 Sofvasc-TelmTelmisartan + Amlodipine 9presentations 10 mg + 40 mg, 10 mg + 80 mg, 5 mg + 40 mg, 5 mg + 80 mg · Tablet #4 EffimoxAmoxicillin 7presentations 125 mg, 125 mg/5 mL, 250 mg, 250 mg/5 mL · Syrup, Capsule #5 IbugesicIbuprofen 7presentations 100 mg, 100 mg/5 mL, 200 mg, 400 mg · Suspension, Tablet #6 Voreta PlusEmpagliflozin + Metformin 6presentations 12.5 mg + 1000 mg, 12.5 mg + 500 mg, 5 mg + 1000 mg · Tablet
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median3828% of comparable products
Near market median58within ±5% of median
Above market median4230% of comparable products
Lowest-price equivalents16ties included
Company median price position -1.4% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Septisol 7.5%Povidone-iodine · Topical solution · 1000ml PKR 0.29/mL-89.3% vs market median Septisol Surgical Scrub 7.5%Povidone-iodine · Surgical scrub solution · 1000ml PKR 0.31/mL-83.5% vs market median Onderon 4 mgOndansetron · Tablet · 12's PKR 19.80/tablet-78.6% vs market median Metwil-XR 1000 mgMetformin · Extended-release tablet · 5x10's PKR 5.67/tablet-59.3% vs market median Septisol Surgical Scrub 7.5%Povidone-iodine · Surgical scrub solution · 60ml PKR 0.98/mL-48.7% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Werrick Pharmaceuticals249 products · 82 generics 43shared generics Macter International Limited256 products · 93 generics 31shared generics Atco Laboratories Limited278 products · 94 generics 30shared generics Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 29shared generics The Searle Company Limited219 products · 71 generics 29shared generics Zafa Pharmaceutical Laboratories (Pvt) Ltd.245 products · 97 generics 27shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers119Distinct registrations among indexed, published, presentation-validated products only
Verified price observations296
Products with a verified price160
Products with multiple price observations136
Source records with multiple versions163
Latest portfolio source check23 Sep 2026
Latest effective price date30 Jun 2026
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

120 unique registration(s) · 172 indexed presentation(s) · 4 additional source-observed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
A2A Losartan 25 mg Tablet 2x10's 022555 PKR 334.92 PKR 16.75/tablet 47% above median
A2A Losartan 50 mg Tablet 2x10's 022556 PKR 634.95 PKR 31.75/tablet 53% above median
Biscot Bisoprolol fumarate 2.5 mg Tablet 1x14's 028240 PKR 49.32 PKR 3.52/tablet 17% below median
Biscot Bisoprolol fumarate 5 mg Tablet 28's 028241 PKR 222.10 PKR 7.93/tablet 35% below median
Biscot Bisoprolol fumarate 5 mg Tablet 1x14's 028241 PKR 113.33 PKR 8.10/tablet 33% below median
Biscot Bisoprolol fumarate 10 mg Tablet 28's 028242 PKR 444.42 PKR 15.87/tablet 28% below median
Biscot Bisoprolol fumarate 10 mg Tablet 1x14's 028242 PKR 226.66 PKR 16.19/tablet 27% below median
BISOLOL Bisoprolol fumarate 5 mg Tablet 20's 094083 PKR 219.96 PKR 11.00/tablet 9% below median
BISOLOL Bisoprolol fumarate 2.5 mg Tablet 14's 094094 PKR 54.27 PKR 3.88/tablet 9% below median
C 1000 Effervescent Ascorbic acid 1000 mg Tablet 10's 106130 PKR 62.39 PKR 6.24/tablet No comparator
CARBINE SR Carbamazepine 200 mg Capsule 20's 029095 PKR 84.46 PKR 4.22/capsule Near median
CARBINE SR Carbamazepine 400 mg Capsule 20's 029096 PKR 425.25 PKR 21.26/capsule 177% above median
Cardiotec Enalapril 10 mg Tablet 1x20's 007585 PKR 348.84 PKR 17.44/tablet 141% above median
Cardiotec Enalapril 20 mg Tablet 20's 007706 PKR 636.37 PKR 31.82/tablet Near median
Cardiotec Enalapril 5 mg Tablet 1x20's 010029 PKR 85.45 PKR 4.27/tablet 19% below median
CV-150 Acetylsalicylic acid (Aspirin) 150 mg Tablet 30's 046208 PKR 73.15 PKR 2.44/tablet Near median
CV-75 Acetylsalicylic acid (Aspirin) 75 mg Tablet 30's 046207 PKR 52.26 PKR 1.74/tablet 15% below median
Daclawil Daclatasvir 30 mg Tablet 28's 092157 PKR 4,895.36 PKR 174.83/tablet 9% below median
Daclawil Daclatasvir 60 mg Tablet 28's 092158 PKR 8,009.97 PKR 286.07/tablet 12% below median
Diazepam Diazepam 5 mg Tablet 30's 007587 PKR 59.50 PKR 1.98/tablet 48% above median
Diazepam Diazepam 2 mg Tablet 30's 007703 PKR 29.75 PKR 0.99/tablet 29% above median
DICLAZIDE Gliclazide 80 mg Tablet 20's 010090 PKR 226.60 PKR 11.33/tablet 9% above median
Effimox Amoxicillin 125 mg/5 mL Syrup 90ml 011949 PKR 130.22 PKR 1.45/mL Near median
Effimox Amoxicillin 125 mg/5 mL Syrup 60ml 011949 PKR 87.18 PKR 1.45/mL Near median
Effimox Amoxicillin 125 mg Syrup 60ml 011949 PKR 87.18 PKR 1.45/mL No comparator
Effimox Amoxicillin 250 mg/5 mL Syrup 90ml 011950 PKR 193.13 PKR 2.15/mL Near median
Effimox Amoxicillin 250 mg/5 mL Syrup 60ml 011950 PKR 128.02 PKR 2.13/mL Near median
Effimox Amoxicillin 250 mg Capsule 2x10's 011951 PKR 215.20 PKR 10.76/capsule Near median
Effimox Amoxicillin 500 mg Capsule 2x10's 011952 PKR 388.47 PKR 19.42/capsule Near median
ENCID Omeprazole 10 mg Capsule 14's 002270 PKR 320.15 PKR 22.87/capsule 121% above median
ENCID Omeprazole 20 mg Capsule 14's 018634 PKR 964.27 PKR 68.88/capsule 250% above median
Encid Omeprazole 20 mg Capsule 2x7's 018634 PKR 934.91 PKR 66.78/capsule 240% above median
ENCID Omeprazole 40 mg Capsule 14's 023059 PKR 529.12 PKR 37.79/capsule 9% above median
ENCID-M Omeprazole 20 mg Tablet 14's 075375 PKR 253.39 PKR 18.10/tablet 7% below median
ENOX Enoxaparin 60 mg Injection 0.6ml/1's 056919 PKR 1,194.09 PKR 1,990.15/mL 19% above median
ERADICIN Cephalexin 250 mg Capsule 12's 017702 PKR 174.02 PKR 14.50/capsule 8% below median
ERADICIN Cephalexin 500 mg Capsule 12's 017703 PKR 341.22 PKR 28.44/capsule 8% below median
FERWIL Iron 100 mg Tablet 10's 056993 PKR 123.18 PKR 12.32/tablet Near median
FERWIL Elemental Iron 50 mg/mL Oral drops 15ml 056994 PKR 114.38 PKR 7.63/mL No comparator
FERWIL Elemental Iron 50 mg/5 mL Syrup 60ml 056995 PKR 123.18 PKR 2.05/mL 12% below median
Flo Isosorbide mononitrate 20 mg Tablet 2x10's 024734 PKR 149.05 PKR 7.45/tablet Near median
Flo-SR Isosorbide 5-mononitrate 60 mg Sustained-release tablet 3x10's 027582 PKR 776.71 PKR 25.89/tablet No comparator
FLOXETIN Fluoxetine 20 mg Capsule 10's 029589 PKR 105.58 PKR 10.56/capsule 19% below median
HYPODOPA Methyldopa 250 mg Tablet 30's 006880 PKR 461.52 PKR 15.38/tablet Near median
Ibugesic Ibuprofen 200 mg Tablet 500's 013139 PKR 1,100.96 PKR 2.20/tablet Near median
Ibugesic Ibuprofen 200 mg Tablet 30's 013139 PKR 66.05 PKR 2.20/tablet Near median
Ibugesic Ibuprofen 400 mg Tablet 250's 023892 PKR 835.48 PKR 3.34/tablet Near median
Ibugesic Ibuprofen 100 mg/5 mL Suspension 120ml 029577 PKR 129.12 PKR 1.08/mL 14% above median
Ibugesic Ibuprofen 100 mg/5 mL Suspension 90ml 029577 PKR 96.84 PKR 1.08/mL 14% above median
Ibugesic Ibuprofen 100 mg Suspension 120ml 029577 PKR 129.12 PKR 1.08/mL 8% above median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Wilson's Pharmaceuticals — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/company/wilsons-pharmaceuticals/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.